Safety and efficacy of TTFields therapy prior and concomitant to radiotherapy in newly diagnosed glioblastoma - the PriCoTTF phase I/II trial

被引：0
|
作者：
Kebir, Sied [1 ]
Lazaridis, Lazaros [1 ]
Schmidt, Teresa [1 ]
Oster, Christoph [1 ]
Feldheim, Jonas [1 ]
Proescholdt, Martin [2 ]
Hau, Peter [2 ]
Grosu, Anca Ligia [3 ]
Krex, Dietmar [4 ]
Pierscianek, Daniela [5 ]
Sure, Ulrich [5 ]
Scheffler, Bjoern [6 ,7 ,8 ]
Kleinschnitz, Christoph [1 ]
Stuschke, Martin [9 ]
Glas, Martin [1 ]
机构：
[1] Univ Duisburg Essen, Univ Med Essen, Div Clin Neurooncol, Dept Neurol,Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany
[2] Univ Med Ctr Regensburg, Dept Neurosurg, Regensburg, Germany
[3] Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany
[4] Univ Hosp Dresden, Dept Neurosurg, Dresden, Germany
[5] Univ Hosp Essen, Dept Neurosurg & Spine Surg, Essen, Germany
[6] Univ Med Essen, West German Canc Ctr WTZ, DKFZ Div Translat Neurooncol, Essen, Germany
[7] German Canc Consortium DKTK, Partner Site, Essen, Germany
[8] German Canc Res Ctr, Essen, Germany
[9] Univ Hosp Essen, Dept Radiotherapy, Essen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
VS09-1-jD
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [41] A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
    Rosenfeld, Myrna R.
    Ye, Xiaobu
    Supko, Jeffrey G.
    Desideri, Serena
    Grossman, Stuart A.
    Brem, Steven
    Mikkelson, Tom
    Wang, Daniel
    Chang, Yunyoung C.
    Hu, Janice
    McAfee, Quentin
    Fisher, Joy
    Troxel, Andrea
    Piao, Shengfu
    Heitjan, Daniel F.
    Tan, Kay See
    Pontiggia, Laura
    O'Dwyer, Peter J.
    Davis, Lisa E.
    Amaravadi, Ravi K.
    AUTOPHAGY, 2014, 10 (08) : 1359 - 1368
  • [42] A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma
    Brown, Paul D.
    Chung, Caroline
    Liu, Diane D.
    McAvoy, Sarah
    Grosshans, David
    Al Feghali, Karine
    Mahajan, Anita
    Li, Jing
    McGovern, Susan L.
    Mcaleer, Mary-Fran
    Ghia, Amol J.
    Sulman, Erik P.
    Penas-Prado, Marta
    de Groot, John F.
    Heimberger, Amy B.
    Wang, Jihong
    Armstrong, Terri S.
    Gilbert, Mark R.
    Guha-Thakurta, Nandita
    Wefel, Jeffrey S.
    NEURO-ONCOLOGY, 2021, 23 (08) : 1337 - 1347
  • [43] A Phase I/II Clinical Trial of Hyperfractionated Concomitant Boost Proton Radiotherapy for Supratentorial Glioblastoma Multiforme
    Tsuboi, K.
    Mizumoto, M.
    Igaki, H.
    Yamamoto, T.
    Takano, S.
    Okumura, T.
    Sakurai, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S231 - S231
  • [44] Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
    Lai, Shuzhen
    Li, Peijing
    Liu, Xiaohui
    Liu, Guihong
    Xie, Tieming
    Zhang, Xing
    Wang, Xiaoxuan
    Huang, Jing
    Tang, Yiqiang
    Liu, Zhigang
    Shen, Guoping
    Li, Chaoming
    Lu, Fangxiao
    Wang, Lei
    Jiang, Fagui
    Sun, Caixing
    Chen, Yuanyuan
    Chen, Ming
    CANCER BIOLOGY & MEDICINE, 2024, 21 (05)
  • [45] EFFICACY AND SAFETY OF STUPP REGIMEN WITH OR WITHOUT ANLOTINIB FOR NEWLY DIAGNOSED GLIOBLASTOMA: A MULTICENTER, DOUBLE-BLIND, RANDOMIZED PHASE II TRIAL
    Chen, Y.
    Liu, G.
    Sun, P.
    Li, M.
    Yang, X.
    Pan, L.
    Wang, L.
    Hua, Y.
    Zhao, M.
    Liu, Y.
    Ran, J.
    Cai, H.
    Lu, X.
    Jiang, H.
    Li, X.
    Zheng, W.
    Liu, Z.
    Lin, S.
    Deng, M.
    Yang, Q.
    Guo, C.
    Li, J.
    Chen, Z.
    NEURO-ONCOLOGY, 2024, 26
  • [46] Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma
    Faye, Mame Daro
    Easaw, Jacob
    De Robles, Paula
    Agnihotram, Raman
    Torres-Vasquez, Alexander
    Lamonde, Frederic
    Petrecca, Kevin
    Owen, Scott
    Panet-Raymond, Valerie
    Shenouda, George
    Souhami, Luis
    Azam, Maryam
    Hossain, Bushra
    Alkass, Jad
    Sabri, Siham
    Abdulkarim, Bassam
    NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
  • [47] Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Vaz, M. A.
    del Barco, S.
    Sepulveda, J. M.
    Alonso, M.
    Pineda, E.
    Balana, C.
    Martinez-Garcia, M.
    Girones, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S393 - S393
  • [48] SAFETY AND EFFICACY OF BEVACIZUMAB PLUS TTFIELDS IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM): DATA FROM A PHASE II CLINICAL TRIAL
    Fallah, Jaleh
    Chaudhary, Rekha
    Rogers, Lisa
    Wei, Wei
    Brewer, Cathy
    Peereboom, David
    Ahluwalia, Manmeet
    NEURO-ONCOLOGY, 2019, 21 : 18 - 18
  • [49] Updated Safety And Feasibility Study Of Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy For Newly Diagnosed Glioblastoma
    Grossman, R.
    Bokstein, F.
    Blumenthal, D.
    Limon, D.
    Ben Harosh, C.
    Ram, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E668 - E668
  • [50] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    James, Allan
    McBain, Catherine
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    NEURO-ONCOLOGY, 2018, 20 : 20 - 20
12345